PhilHealth is not about its organization, infrastructure, institutional expertise, or even its funds. It embodies a dream—a material lifeline for survival. This dream may not be shared by all ...

Prepping for a potential crisis means you need to establish a sustainable food supply that can withstand the test of time. By ...

Omeros is putting up its monoclonal antibody up for FDA approval—again. | Omeros is putting up its monoclonal antibody up for ...

TMA-001, compared overall survival in 28 TA-TMA patients treated with narsoplimab to more than 100 high-risk TA-TMA patients in an external control registry who did not receive the treatment. The ...

(THE CONVERSATION) Holidays are often depicted as picture-perfect moments: families blissfully united around a table filled with seasonal food favorites against an immaculate backdrop. For many ...

Zymeworks' transformation and execution have positioned them for success, with new drug approvals and promising phase 3 ...

But one foodbank in Porirua, run by Wellington iwi Ngāti Toa, says collaboration and connection are what helped it survive a tough year to keep feeding the community. Te Umu Ki Rangituhi is working ...

According to Guardant’s website, Medicare Part B (Medical Insurance) covers a blood-based biomarker screening test to check for colorectal cancer if the individual is between the ages of 45–85, shows ...

Following a complete response letter and biologics license application resubmission, the FDA has approved remestemcel-L for ...

The US Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the treatment of adults with ALK-positive locally advanced or metastatic non-small cell lung ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...